| Far-red light-activatable prodrug of paclitaxel for the combined effects of photodynamic therapy and site-specific paclitaxel chemotherapy P Thapa, M Li, M Bio, P Rajaputra, G Nkepang, Y Sun, S Woo, Y You Journal of medicinal chemistry 59 (7), 3204-3214, 2016 | 110 | 2016 |
| Click and photo-unclick chemistry of aminoacrylate for visible light-triggered drug release M Bio, G Nkepang, Y You Chemical communications 48 (52), 6517-6519, 2012 | 104 | 2012 |
| Site-specific and far-red-light-activatable prodrug of combretastatin A-4 using photo-unclick chemistry M Bio, P Rajaputra, G Nkepang, SG Awuah, AML Hossion, Y You Journal of medicinal chemistry 56 (10), 3936-3942, 2013 | 97 | 2013 |
| Visible light controlled release of anticancer drug through double activation of prodrug AML Hossion, M Bio, G Nkepang, SG Awuah, Y You ACS medicinal chemistry letters 4 (1), 124-127, 2013 | 92 | 2013 |
| Far-red light activatable, multifunctional prodrug for fluorescence optical imaging and combinational treatment M Bio, P Rajaputra, G Nkepang, Y You Journal of medicinal chemistry 57 (8), 3401-3409, 2014 | 81 | 2014 |
| Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor G Nkepang, M Bio, P Rajaputra, SG Awuah, Y You Bioconjugate Chemistry 25 (12), 2175-2188, 2014 | 76 | 2014 |
| Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria P Rajaputra, G Nkepang, R Watley, Y You Bioorganic & medicinal chemistry 21 (2), 379-387, 2013 | 62 | 2013 |
| Folate-PEG conjugates of a far-red light-activatable paclitaxel prodrug to improve selectivity toward folate receptor-positive cancer cells P Thapa, M Li, R Karki, M Bio, P Rajaputra, G Nkepang, S Woo, Y You ACS omega 2 (10), 6349-6360, 2017 | 41 | 2017 |
| Surface modification of liposomes by a lipopolymer targeting prostate specific membrane antigen for theranostic delivery in prostate cancer H Yari, G Nkepang, V Awasthi Materials 12 (5), 756, 2019 | 39 | 2019 |
| Anticancer drug released from near IR-activated prodrug overcomes spatiotemporal limits of singlet oxygen P Rajaputra, M Bio, G Nkepang, P Thapa, S Woo, Y You Bioorganic & medicinal chemistry 24 (7), 1540-1549, 2016 | 30 | 2016 |
| Stability study on an anti-cancer drug 4-(3, 5-bis (2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method D Raghuvanshi, G Nkepang, A Hussain, H Yari, V Awasthi Journal of pharmaceutical analysis 7 (1), 1-9, 2017 | 20 | 2017 |
| Synthesis and singlet oxygen reactivity of 1, 2‐diaryloxyethenes and selected sulfur and nitrogen analogs G Nkepang, PK Pogula, M Bio, Y You Photochemistry and Photobiology 88 (3), 753-759, 2012 | 20 | 2012 |
| Imaging of isoproterenol-induced myocardial injury with 18F labeled fluoroglucaric acid in a rat model HA Houson, GN Nkepang, AF Hedrick, V Awasthi Nuclear medicine and biology 59, 9-15, 2018 | 16 | 2018 |
| Facile synthesis of para-[18F] fluorohippurate via iodonium ylide-mediated radiofluorination for PET renography GN Nkepang, AF Hedrick, V Awasthi, H Gali Bioorganic & Medicinal Chemistry Letters 26 (2), 479-483, 2016 | 11 | 2016 |
| Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24 G Rao, H Houson, G Nkepang, H Yari, C Teng, V Awasthi American Journal of Physiology-Gastrointestinal and Liver Physiology 315 (2 …, 2018 | 10 | 2018 |
| Ubiquitin receptor RPN13 mediates the inhibitory interaction of diphenyldihaloketones CLEFMA and EF24 with the 26S proteasome G Rao, G Nkepang, J Xu, H Yari, H Houson, C Teng, V Awasthi Frontiers in Chemistry 6, 392, 2018 | 7 | 2018 |
| Production of [13N] ammonia from [13C] methanol on a 7.5 MeV cyclotron using 13C (p, N) 13N reaction: detection of myocardial infarction in a mouse model GN Nkepang, H Gali, H Houson, AF Hedrick, B Hayes, O Causey, ... Applied Radiation and Isotopes 150, 19-24, 2019 | 3 | 2019 |
| Heteroatom‐substitued Dioxetanes and their Emerging Biomedical Applications G NKEPANG, Y YOU PATAI'S Chemistry of Functional Groups, 1-29, 2009 | 2 | 2009 |
| Feasibility of 13N-ammonia production by 13C (p, n) 13N reaction on a 7.5 MeV cyclotron G Nkepang, H Houson, H Gali, V Awasthi Journal of Nuclear Medicine 59 (supplement 1), 663-663, 2018 | 1 | 2018 |
| Singlet oxygen-labile linkers and methods of production and use thereof Y You, M Bio, AG Hossion, G Nkepang US Patent 9,839,690, 2017 | 1 | 2017 |
